Amphetamine-induced disruption of latent inhibition is not reinforcer-mediated

Pharmacology Biochemistry and Behavior

Volumn 56, Issue 4, 1997, Pages 817-826

  Weiner, I ^a   Tarrasch, R ^a   Bernasconi, E ^b   Broersen, L M ^b   Ruttimann T C ^b   Feldon, J ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b SWISS FEDERAL INSTITUTE OF TECHNOLOGY   (Switzerland)

Author keywords

amphetamine; dopamine; latent inhibition; rat; schizophrenia; switching

Indexed keywords

DEXAMPHETAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; ELECTRIC SHOCK; EMOTION; INTRAPERITONEAL DRUG ADMINISTRATION; LATENT INHIBITION; LICKING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REINFORCEMENT; SCHIZOPHRENIA;

ANIMALS; CONDITIONING (PSYCHOLOGY); DEXTROAMPHETAMINE; DOPAMINE AGENTS; FEMALE; INHIBITION (PSYCHOLOGY); MALE; RATS; RATS, WISTAR; REINFORCEMENT (PSYCHOLOGY);

ANIMALIA;

EID: 0030887243     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00417-0     Document Type: Article

References (53)

1. Anscombe F. The disorder of consciousness in schizophrenia. Schiz. Bull. 13:1987;241-260.
2. Baruch I., Hemsley D., Gray J. A. Differential performance of acute and chronic schizophrenics in a latent inhibition task. J. Nerv. Ment. Dis. 176:1988;598-606.
3. Baruch I., Hemsley D. R., Gray J. A. Latent inhibition and "psychotic proneness" in normal subjects. Pers. Indiv. Differ. 9:1988;777-783.
4. Bleuler E. Dementia praecox or the group of schizophrenias. 1911;International Universities Press, New York.
5. Broen W. E. Schizophrenia. Research and theory:1968;Academic Press, New York.
6. Christison G. W., Atwater G. E., Dunn L. A., Kilts C. D. Haloperidol enhancement of latent inhibition. Relation to therapeutic action? Biol. Psychiatry. 23:1988;746-749.
7. Cools A., Jaspers R., Schwartz M., Sontag K. H., Vrijmoed de Vries M., Van den Bereken J. Basal ganglia and switching motor programs. McKenzie J. S., Kemm R. E., Wilcock N. The basal ganglia. 1984;513-544 Plenum Press, New York.
8. De la Casa L. G., Ruiz G., Lubow R. E. Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration. Implications for schizophrenia Biol. Psychiatry. 33:1993;707-711.
9. De la Casa L. G., Ruiz G., Lubow R. E. Latent inhibition and recall/recognition of irrelevant stimuli as a function of preexposure duration in high and low psychotic-prone normals. Br. J. Psychol. 84:1993;119-132.
10. Di Chiara G. On the preferential release of mesolimbic dopamine by amphetamine. Neuropsychopharmacology. 5:1991;243-244.
11. Dunn L. A., Atwater G. E., Kilts C. D. Effects of antipsychotic drugs on latent inhibition - Sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology. 112:1993;315-323.
12. Feldon J., Weiner I. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli Biol. Psychiatry. 29:1991;635-646.
13. Frith C. D. Consciousness, information processing and schizophrenia. Br. J. Psychiatry. 134:1979;225-235.
14. Frith C. D. The cognitive neuropsychology of schizophrenia. Essays in cognitive psychology. 1992;Lawrence Erlbaum Associates Ltd, Hillsdale, NJ.
15. Gelissen M., Cools A. Effect of intracaudate haloperidol and apomorphine on switching motor patterns upon current behavior of cats. Behav. Brain Res. 29:1988;17-26.
16. Gray J. A., Feldon J., Rawlins J. N. P., Hemsley D. R., Smith A. D. The neuropsychology of schizophrenia. Behav. Brain Sci. 14:1991;1-84.
17. Gray J. A., Joseph M. H., Hemsley D. R., Young A. M. J., Warburton E. C., Boulenguez P.et al. The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition. Implications for schizophrenia Behav. Brain Res. 71:1995;19-31.
18. Gray N. S., Hemsley D. R., Gray J. A. Abolition of latent inhibition in acute, but not chronic, schizophrenics. Neurol. Psychiatry Brain Res. 1:1992;83-89.
19. Gray N. S., Pickering A. D., Hemsley D. R., Dawling S., Gray J. A. Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man. Psychopharmacology. 107:1992;425-430.
20. Gray N. S., Pilowsky L. S., Gray J. A., Kerwin R. W. Latent inhibition in drug naive schizophrenics. Relationship to duration of illness and dopamine D2 binding using SPET Schizophr. Res. 17:1995;95-107.
21. Hall G. Perceptual and associative learning. 1991;Oxford University Press, New York.
22. Killcross A. S., Dickinson A., Robbins T. W. Amphetamine-induced disruptions of latent inhibition are reinforcer-mediated. Implications for animal models of schizophrenic attentional dysfunction Psychopharmacology. 115:1994;185-195.
23. Killcross A. S., Robbins T. W. Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm. Psychopharmacology. 110:1993;479-489.
24. Kuczenski R., Segal D. Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis. J. Neurosci. 9:1989;2051-2065.
25. Lipp O. V., Vaitl D. Latent inhibition in human Pavlovian differential conditioning. Effect of additional stimulation after preexposure and relation to schizotypal traits Pers. Indiv. Differ. 13:1992;1003-1012.
26. Lubow R. E. Latent inhibition. Psychol. Bull. 79:1973;398-407.
27. Lubow R. E. Latent inhibition and conditioned attention theory. 1989;Cambridge University Press, Cambridge, UK.
28. Lubow R. E., Gewirtz J. C. Latent inhibition in humans. Data, theory, and implications for schizophrenia Psychol. Bull. 117:1995;87-103.
29. Lubow R. E., Ingberg-Sachs Y., Zalstein-Orda N., Gewirtz J. C. Latent inhibition in low and high "psychotic-prone" subjects. Pers. Indiv. Differ. 13:1992;563-572.
30. Lubow R. E., Weiner I., Schnur P. Conditioned attention theory. Bower G. H. The psychology of learning and motivation. 1981;1-49 Academic Press, New York.
31. Lyon M. Animal models of mania and schizophrenia. Willner P. Behavioral models in psychopharmacology. Theoretical, industrial and clinical perspectives:1991;253-310 Cambridge University Press, Cambridge, UK.
32. Mackintosh N. J. A theory of attention. Variations in the associability of stimuli with reinforcement Psychol. Rev. 82:1975;276-298.
33. Mackintosh N. J. Conditioning and associative learning. 1983;Oxford University Press, New York.
34. Magaro P. A. Cognition in schizophrenia and paranoia. The integration of cognitive processes:1980;Lawrence Erlbaum, Hillsdale, NJ.
35. Moore J. W., Stickney K. J. Formation of attentional-associative networks in real time. Role of the hippocampus and implications for conditioning Physiol. Psychol. 8:1980;207-217.
36. Oades R. D. The role of noradrenaline in tuning and dopamine in switching between signals in the CNS. Neurosci. Biobehav. Rev. 9:1985;261-282.
37. Payne R. W. The measurement and significance of overinclusive thinking and retardation in schizophrenic patients. Hoch P., Zubin J. Psychopathology of schizophrenia. 1966;Grune and Stratton, New York.
38. Robbins T. W. The case for frontostriatal dysfunction in schizophrenia. Schiz. Bull. 16:1990;391-402.
39. Robbins T. W., Everitt B. J. Functional studies of the central catecholamines. Int. Rev. Neurobiol. 23:1982;303-365.
40. Schmajuk N. A., Moore J. W. Real-time attentional models for classical conditioning and the hippocampus. Physiol. Psychol. 13:1985;278-290.
41. Schmajuk N. A., Moore J. W. The hippocampus and the classically conditioned nictitating membrane response. A real-time attentional-associative model Psychobiology. 16:1988;20-35.
42. Shakow D. Segmental set. A theory of the formal psychological deficit in schizophrenia Arch. Gen. Psychiatry. 6:1962;17-33.
43. Solomon P. R., Crider A., Winkelman J. W., Turi A., Kamer R. M., Kaplan L. J. Disrupted latent inhibition in the rat with chronic amphetamine or haloperidol-induced supersensitivity. Relationship to schizophrenic attention disorder Biol. Psychiatry. 16:1981;519-537.
44. Staton D. M., Solomon P. Microinjections of d-amphetamine into the nucleus accumbens and caudate-putamen differentially affect stereotypy and locomotion in the rat. Physiol. Psychol. 12:1984;159-162.
45. Swerdlow N. R., Koob G. F. Dopamine, schizophrenia, mania and depression. Toward a unified hypothesis of cortico-striato-pallido-thalamic function Behav. Brain Res. 10:1987;197-245.
46. Van den Bos R., Cools A. R. The involvement of the nucleus accumbens in the ability of rats to switch to cue-directed behaviors. Life Sci. 44:1989;1697-1704.
47. Warburton E. C., Joseph M. H., Feldon J., Weiner I., Gray J. A. Antagonism of amphetamine-induced disruption of LI in rats by haloperidol and ondansetron. Implications for a possible antipsychotic action of ondansetron Psychopharmacology. 114:1994;657-664.
48. Weiner I. Neural substrates of latent inhibition. The switching model Psychol. Bull. 108:1990;442-461.
49. Weiner I., Izraeli-Telerant A., Feldon J. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine. Psychopharmacology. 91:1987;345-351.
50. Weiner I., Lubow R. E., Feldon J. Chronic amphetamine and latent inhibition. Behav. Brain Res. 2:1981;285-286.
51. Weiner I., Lubow R. E., Feldon J. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats. Psychopharmacology. 83:1984;194-199.
52. Weiner I., Lubow R. E., Feldon J. Disruption of latent inhibition by acute administration of low doses of amphetamine. Pharmacol. Biochem. Behav. 30:1988;871-878.
53. Weiner, I.; Shadach, E.; Barkai, R.; Feldon, J.: Haloperidol and clozapine-induced enhancement of latent inhibition with extended conditioning: Implications for the mechanism of action of neuroleptic drugs. Neuropsychopharmacology; in press.